News
Drug resistance biomarker could improve cancer treatmentDrug resistance biomarker could improve cancer treatment
Cancer therapies often have short-lived benefits due to the emergence of genetic mutations that cause drug resistance. A key gene...
News
Discovery of molecular pathway of Alzheimer’s disease reveals new drug targets
The discovery of the molecular pathway that drives the changes seen in the brains of Alzheimer's patients is reported today, revealing new targets for...
News
TGen, Scottsdale Healthcare lead worldwide study of new drug for patients with pancreatic cancer
A new cancer drug combination demonstrated significant improvement in overall survival of late-stage pancreatic cancer patients compared to those receiving standard treatment, according to...
News
Study shows large-scale genomic testing feasible, impacts therapy
Targeted cancer therapy has been transforming the care of patients with non-small-cell lung cancer (NSCLC). It is now standard practice for...
News
Cook Medical’s Zilver® PTX® Earns FDA Approval As First Drug-Eluting Stent in U.S. to Treat Peripheral Arterial Disease
Cook Medical has received U.S. Food and Drug Administration (FDA) marketing approval for the first devices in its Zilver® PTX® Drug-Eluting Peripheral Stentportfolio, company...
News
Bristol-Myers Squibb Foundation’s Together on Diabetes™ marks World Diabetes Day
The Bristol-Myers Squibb Foundation has marked World Diabetes Day and the second anniversary of its Together on Diabetes™ initiative by issuing the initiative's second...
News
The largest clinical study of Bayer’s Xarelto® (rivaroxaban)
Bayer HealthCare has announced the initiation of the COMPASS study, the largest clinical study of its oral anticoagulant Xarelto® (rivaroxaban) to date, investigating the...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.